Global Endoscopic Bariatric Therapy (EBT) Market Growth 2025-2031

The global Endoscopic Bariatric Therapy (EBT) market size is predicted to grow from US$ 172 million in 2025 to US$ 276 million in 2031; it is expected to grow at a CAGR of 8.2% from 2025 to 2031.

Endoscopic Bariatric Therapy (EBT) is a minimally invasive weight loss approach primarily used for treating obesity or overweight patients. This therapy employs endoscopic techniques to modify the gastrointestinal tract, either by reducing stomach volume or altering its anatomy to limit food intake or affect nutrient absorption. Among the various EBT devices developed, the Intragastric Balloon (IGB) is the most widely used in clinical settings. The IGB is inserted into the stomach via endoscopy and inflated with saline or gas, partially filling the stomach to induce a feeling of fullness, thereby reducing food consumption. This therapy is suitable for patients who struggle with weight loss through conventional diet and exercise, offering a safer and reversible alternative to bariatric surgery.

United States market for Endoscopic Bariatric Therapy (EBT) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Endoscopic Bariatric Therapy (EBT) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Endoscopic Bariatric Therapy (EBT) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Endoscopic Bariatric Therapy (EBT) players cover Boston Scientific (Apollo Endosurgery）, ReShape Lifesciences, Allurion, Helioscopie, Endalis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Endoscopic Bariatric Therapy (EBT) Industry Forecast” looks at past sales and reviews total world Endoscopic Bariatric Therapy (EBT) sales in 2024, providing a comprehensive analysis by region and market sector of projected Endoscopic Bariatric Therapy (EBT) sales for 2025 through 2031. With Endoscopic Bariatric Therapy (EBT) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Endoscopic Bariatric Therapy (EBT) industry.

This Insight Report provides a comprehensive analysis of the global Endoscopic Bariatric Therapy (EBT) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Endoscopic Bariatric Therapy (EBT) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Endoscopic Bariatric Therapy (EBT) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Endoscopic Bariatric Therapy (EBT) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Endoscopic Bariatric Therapy (EBT).

This report presents a comprehensive overview, market shares, and growth opportunities of Endoscopic Bariatric Therapy (EBT) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Intragastric Balloon
Others

Segmentation by Application:
Male
Female

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Boston Scientific (Apollo Endosurgery）
ReShape Lifesciences
Allurion
Helioscopie
Endalis
MEDSIL
Spatz Medical
Lexel
Districlass Medical
Silimed
Changzhou Panda Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Endoscopic Bariatric Therapy (EBT) market?

What factors are driving Endoscopic Bariatric Therapy (EBT) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Endoscopic Bariatric Therapy (EBT) market opportunities vary by end market size?

How does Endoscopic Bariatric Therapy (EBT) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more